Adalimumab

RX_L04AB04

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AB04

2079

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1855

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1855

diagram downward connector

Include endpoints None

1855

diagram downward connector
RX_L04AB04

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 1855 1104 751
Unadjusted prevalence (%) 0.52 0.56 0.48
Mean age at first event (years) 46.45 45.87 47.29

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.92 [0.96, 3.86] 6.7e-2 34
15 years 0.01 1.07 [0.50, 2.29] 8.5e-1 19
5 years 0.00 2.03 [0.93, 4.44] 7.6e-2 11
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_L04AB04 – Adalimumab
GWS hits:

Survival analyses between endpoints

Plot

before Adalimumab
after Adalimumab

loading spinner Loading survival analyses plot